White Plains, NY, United States of America

Bolanle Akinlade

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Bolanle Akinlade: Innovator in Dermatological Treatments

Introduction

Bolanle Akinlade is a prominent inventor based in White Plains, NY (US). She has made significant contributions to the field of dermatology, particularly in the treatment of severe atopic dermatitis. With a total of 2 patents to her name, Akinlade's work is paving the way for innovative therapeutic approaches.

Latest Patents

Akinlade's latest patents focus on methods for treating moderate-to-severe or severe atopic dermatitis by administering an interleukin-4 receptor (IL-4R) inhibitor. The present invention provides methods that involve administering to a subject in need one or more doses of an anti-IL-4R antibody. These methods are particularly beneficial for patients whose severe atopic dermatitis is not controlled with systemic therapy, such as cyclosporine A, or when such therapy is inadvisable.

Career Highlights

Throughout her career, Bolanle Akinlade has worked with leading companies in the biotechnology sector, including Regeneron Pharmaceuticals, Inc. and Sanofi Biotechnology. Her experience in these organizations has allowed her to develop and refine her innovative approaches to treating dermatological conditions.

Collaborations

Akinlade has collaborated with notable professionals in her field, including Allen Radin and Neil John Graham. These collaborations have further enhanced her research and development efforts in dermatology.

Conclusion

Bolanle Akinlade is a trailblazer in the field of dermatological treatments, with her innovative patents addressing critical health issues. Her work continues to impact the lives of patients suffering from severe atopic dermatitis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…